134 related articles for article (PubMed ID: 38531528)
1. Regulatory and therapeutic implications of competing endogenous RNA network in breast cancer progression and metastasis: A review.
Saranya I; Dharshini VS; Akshaya RL; Subhashini PS; Selvamurugan N
Int J Biol Macromol; 2024 May; 266(Pt 2):131075. PubMed ID: 38531528
[TBL] [Abstract][Full Text] [Related]
2. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
3. Systematical analysis of lncRNA-mRNA competing endogenous RNA network in breast cancer subtypes.
Zhou S; Wang L; Yang Q; Liu H; Meng Q; Jiang L; Wang S; Jiang W
Breast Cancer Res Treat; 2018 Jun; 169(2):267-275. PubMed ID: 29388017
[TBL] [Abstract][Full Text] [Related]
4. Competing endogenous RNA network analysis identifies critical genes among the different breast cancer subtypes.
Chen J; Xu J; Li Y; Zhang J; Chen H; Lu J; Wang Z; Zhao X; Xu K; Li Y; Li X; Zhang Y
Oncotarget; 2017 Feb; 8(6):10171-10184. PubMed ID: 28052038
[TBL] [Abstract][Full Text] [Related]
5. Competitive Endogenous RNA (ceRNA) Regulation Network of lncRNA-miRNA-mRNA in Colorectal Carcinogenesis.
Liu J; Li H; Zheng B; Sun L; Yuan Y; Xing C
Dig Dis Sci; 2019 Jul; 64(7):1868-1877. PubMed ID: 30734239
[TBL] [Abstract][Full Text] [Related]
6. ncRNA-mediated ceRNA regulatory network: Transcriptomic insights into breast cancer progression and treatment strategies.
Yang S; Wang X; Zhou X; Hou L; Wu J; Zhang W; Li H; Gao C; Sun C
Biomed Pharmacother; 2023 Jun; 162():114698. PubMed ID: 37060661
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of the lncRNA‑associated competing endogenous RNA network in breast cancer.
Wang JJ; Huang YQ; Song W; Li YF; Wang H; Wang WJ; Huang M
Oncol Rep; 2019 Dec; 42(6):2572-2582. PubMed ID: 31638237
[TBL] [Abstract][Full Text] [Related]
8. Construction of a competing endogenous RNA network using differentially expressed lncRNAs, miRNAs and mRNAs in non‑small cell lung cancer.
Wang XW; Guo QQ; Wei Y; Ren KM; Zheng FS; Tang J; Zhang HY; Zhao JG
Oncol Rep; 2019 Dec; 42(6):2402-2415. PubMed ID: 31638248
[TBL] [Abstract][Full Text] [Related]
9. Competing endogenous RNA (ceRNA) cross talk and language in ceRNA regulatory networks: A new look at hallmarks of breast cancer.
Abdollahzadeh R; Daraei A; Mansoori Y; Sepahvand M; Amoli MM; Tavakkoly-Bazzaz J
J Cell Physiol; 2019 Jul; 234(7):10080-10100. PubMed ID: 30537129
[TBL] [Abstract][Full Text] [Related]
10. Competitive endogenous RNA (ceRNA) regulation network of lncRNAs, miRNAs, and mRNAs in Wilms tumour.
Tang F; Lu Z; Wang J; Li Z; Wu W; Duan H; He Z
BMC Med Genomics; 2019 Dec; 12(1):194. PubMed ID: 31842887
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a non-coding RNA-associated ceRNA network in metastatic lung adenocarcinoma.
Fan F; Ping Y; Yang L; Duan X; Resegofetse Maimela N; Li B; Li X; Chen J; Zhang K; Wang L; Liu S; Zhao X; Wang H; Zhang Y
J Cell Mol Med; 2020 Oct; 24(20):11680-11690. PubMed ID: 32860342
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers.
Kong X; Qi J; Yan Y; Chen L; Zhao Y; Fang Z; Fan J; Liu M; Liu Y
J Cell Biochem; 2019 Oct; 120(10):17963-17974. PubMed ID: 31127661
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of the aberrantly expressed lncRNA‑associated ceRNA network in breast cancer.
Tuersong T; Li L; Abulaiti Z; Feng S
Mol Med Rep; 2019 Jun; 19(6):4697-4710. PubMed ID: 31059025
[TBL] [Abstract][Full Text] [Related]
14. Regulation of Breast Cancer Progression by Noncoding RNAs.
Akshaya RL; Rohini M; Selvamurugan N
Curr Cancer Drug Targets; 2020; 20(10):757-767. PubMed ID: 32652909
[TBL] [Abstract][Full Text] [Related]
15. Construction and comprehensive analysis of a competitive endogenous RNA network to reveal potential biomarkers for the malignant differentiation of glioma.
Li X; Zhang J; Zhang M; Qi X; Wang S; Teng J
Medicine (Baltimore); 2021 Oct; 100(39):e27248. PubMed ID: 34596120
[TBL] [Abstract][Full Text] [Related]
16. Identification of prognostic biomarkers and drug target prediction for colon cancer according to a competitive endogenous RNA network.
Hu D; Zhang B; Yu M; Shi W; Zhang L
Mol Med Rep; 2020 Aug; 22(2):620-632. PubMed ID: 32468035
[TBL] [Abstract][Full Text] [Related]
17. Genomic Alterations Affecting Competitive Endogenous RNAs (ceRNAs) and Regulatory Networks (ceRNETs) with Clinical Implications in Triple-Negative Breast Cancer (TNBC).
Qattan A
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473871
[TBL] [Abstract][Full Text] [Related]
18. Construction and Analysis of Competing Endogenous RNA Networks for Breast Cancer Based on TCGA Dataset.
Wang X; Gao C; Feng F; Zhuang J; Liu L; Li H; Liu C; Wu J; Zheng X; Ding X; Sun C
Biomed Res Int; 2020; 2020():4078596. PubMed ID: 32775417
[TBL] [Abstract][Full Text] [Related]
19. Integrated analysis of co-expression and ceRNA network identifies five lncRNAs as prognostic markers for breast cancer.
Yao Y; Zhang T; Qi L; Zhou C; Wei J; Feng F; Liu R; Sun C
J Cell Mol Med; 2019 Dec; 23(12):8410-8419. PubMed ID: 31613058
[TBL] [Abstract][Full Text] [Related]
20. Identification of competitive endogenous RNAs network in breast cancer.
Wang X; Wan J; Xu Z; Jiang S; Ji L; Liu Y; Zhai S; Cui R
Cancer Med; 2019 May; 8(5):2392-2403. PubMed ID: 30932362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
